Cherokee Insurance Co Invests $3.87 Million in HCA Healthcare, Inc. $HCA

Cherokee Insurance Co purchased a new stake in HCA Healthcare, Inc. (NYSE:HCA) in the second quarter, HoldingsChannel reports. The fund purchased 10,100 shares of the company’s stock, valued at approximately $3,869,000. HCA Healthcare accounts for 1.7% of Cherokee Insurance Co’s portfolio, making the stock its 19th largest holding.

A number of other institutional investors have also added to or reduced their stakes in the company. Price T Rowe Associates Inc. MD raised its holdings in HCA Healthcare by 83.4% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 2,399,372 shares of the company’s stock valued at $829,104,000 after acquiring an additional 1,091,416 shares in the last quarter. Goldman Sachs Group Inc. raised its stake in shares of HCA Healthcare by 49.1% in the first quarter. Goldman Sachs Group Inc. now owns 1,781,459 shares of the company’s stock valued at $615,583,000 after purchasing an additional 587,036 shares in the last quarter. Nuveen LLC acquired a new stake in HCA Healthcare during the first quarter worth $569,217,000. Pacer Advisors Inc. lifted its holdings in shares of HCA Healthcare by 6,237.9% during the 1st quarter. Pacer Advisors Inc. now owns 1,350,933 shares of the company’s stock worth $466,815,000 after acquiring an additional 1,329,618 shares during the period. Finally, Nordea Investment Management AB increased its stake in HCA Healthcare by 6.8% in the second quarter. Nordea Investment Management AB now owns 927,781 shares of the company’s stock valued at $350,404,000 after acquiring an additional 59,163 shares during the period. 62.73% of the stock is owned by institutional investors and hedge funds.

HCA Healthcare Trading Up 2.5%

Shares of NYSE HCA opened at $474.08 on Thursday. The firm’s 50-day moving average is $431.29 and its 200-day moving average is $394.54. The firm has a market capitalization of $108.18 billion, a PE ratio of 18.33, a price-to-earnings-growth ratio of 1.38 and a beta of 1.41. HCA Healthcare, Inc. has a 1 year low of $289.98 and a 1 year high of $479.43.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings data on Friday, October 24th. The company reported $6.96 EPS for the quarter, topping analysts’ consensus estimates of $5.64 by $1.32. HCA Healthcare had a negative return on equity of 792.25% and a net margin of 8.53%.The business had revenue of $19.16 billion during the quarter, compared to analysts’ expectations of $18.55 billion. During the same period in the previous year, the firm earned $4.90 earnings per share. The firm’s quarterly revenue was up 9.6% compared to the same quarter last year. HCA Healthcare has set its FY 2025 guidance at 27.000-28.000 EPS. As a group, equities research analysts anticipate that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Monday, December 29th. Investors of record on Monday, December 15th will be issued a dividend of $0.72 per share. The ex-dividend date is Monday, December 15th. This represents a $2.88 dividend on an annualized basis and a yield of 0.6%. HCA Healthcare’s payout ratio is currently 11.13%.

Insider Buying and Selling at HCA Healthcare

In related news, EVP Michael R. Mcalevey sold 3,892 shares of the company’s stock in a transaction on Wednesday, November 5th. The shares were sold at an average price of $473.79, for a total value of $1,843,990.68. Following the completion of the sale, the executive vice president owned 3,487 shares in the company, valued at $1,652,105.73. This represents a 52.74% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, EVP Michael S. Cuffe sold 3,836 shares of the firm’s stock in a transaction dated Monday, September 8th. The stock was sold at an average price of $418.84, for a total value of $1,606,670.24. Following the sale, the executive vice president directly owned 31,503 shares in the company, valued at approximately $13,194,716.52. This represents a 10.85% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. 1.30% of the stock is owned by insiders.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently weighed in on HCA shares. Robert W. Baird upped their price objective on HCA Healthcare from $380.00 to $423.00 and gave the company a “neutral” rating in a research note on Thursday, August 14th. Wolfe Research cut HCA Healthcare from an “outperform” rating to a “peer perform” rating in a research report on Monday, July 28th. TD Cowen boosted their target price on shares of HCA Healthcare from $380.00 to $490.00 and gave the company a “buy” rating in a research note on Monday, October 27th. Wall Street Zen raised shares of HCA Healthcare from a “buy” rating to a “strong-buy” rating in a report on Saturday, October 25th. Finally, Raymond James Financial set a $525.00 price objective on HCA Healthcare in a research note on Monday, October 27th. One analyst has rated the stock with a Strong Buy rating, fourteen have given a Buy rating and ten have assigned a Hold rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $473.53.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.